Research / GH / Fundamental state Inspectable configuration
State dimensions Filing 0001576280-25-000246 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
480.65% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.43% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-25.98% · OPTIONAL · VALID
Revenue growth 76th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.revenue
30.95% · CORE · VALID
Inventory pressure 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
36.22% · OPTIONAL · VALID
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
65.01% · CORE · NOT_ENOUGH_HISTORY
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-45.85% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
37.68% · OPTIONAL · VALID
SBC intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
18.30% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 22 states Self-history eligible
Sep 30, 2021 0/7 normalized Level 3 Dec 31, 2021 0/7 normalized Level 3 Mar 31, 2022 6/7 normalized Level 3 Jun 30, 2022 6/7 normalized Level 3 Sep 30, 2022 6/7 normalized Level 3 Dec 31, 2022 6/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/9 normalized Level 3 Jun 30, 2025 7/9 normalized Level 3 Sep 30, 2025 7/9 normalized Level 3 Dec 31, 2025 7/9 normalized Level 3 Mar 31, 2026 7/9 normalized Level 3 Jun 30, 2026 7/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 548.65%
Current 480.65%
Delta -68.00% Capex Intensity Increased
Previous 2.19%
Current 2.43%
Delta 0.24% Cash Generation Increased
Previous -30.81%
Current -25.98%
Delta 4.83% Growth Increased
Previous 20.76%
Current 30.95%
Delta 10.19% Inventory Pressure Decreased
Previous 37.97%
Current 36.22%
Delta -1.75% Margin Increased
Previous 63.28%
Current 65.01%
Delta 1.74% Profitability Increased
Previous -54.57%
Current -45.85%
Delta 8.72% R And D Intensity Decreased
Previous 43.51%
Current 37.68%
Delta -5.83% Sbc Intensity Decreased
Previous 18.56%
Current 18.30%
Delta -0.26% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.